Filters
Elevated C-reactive protein (CRP), older age, and chest radiography (CXR) findings are predictive of COVID-19 pneumonia, admission to intensive care unit (ICU), and mortality, according to a Singapore study, adding that prospective studies should be undertaken to validate these findings.
Universal hepatitis B vaccination and antiviral therapy against viral hepatitis have helped minimize hepatocellular carcinoma (HCC) incidence and mortality rates among Taiwan’s young and middle-aged populations, a recent study has found.
Putting off the administration of antimicrobial therapy in patients with suspected infection is risky and may lead to progression to septic shock, a study has found.
The increasing use of social media and online reviews has made it easier for patients to comment publicly—on Facebook and Google reviews, for instance—on the care they receive. Positive comments are heartening for any healthcare professional to read.
The COVID-19 pandemic serves as a timely reminder of the need to address vaccine-preventable diseases (VPDs) that are potentially life-threatening, such as pertussis (whooping cough), from which we can easily protect our most vulnerable group of young infants.
The risk of death from the novel coronavirus disease (COVID-19) seems to be higher among elderly frail patients, a recent study has found.
The latest SARS-CoV-2 mutant to join the league of WHO-declared variant of concern (VOC) —B.1.617.2 (now known as the Delta variant) — has sparked global concern, and for good reasons.
Using olfactory tests could improve monitoring of the novel coronavirus disease (COVID-19) and help curb its spread when used at the entrances of single-day events, a recent study has found.
The SGLT2 inhibitor dapagliflozin did not result in a reduced incidence of organ failure or death in patients with cardiometabolic risk factors who were hospitalized with COVID-19, according to the phase III DARE-19* trial. However, this finding does not support discontinuation of SGLT2 inhibitors in COVID-19 patients.
Persistent lymphopoenia is common patients who had recovered from the novel coronavirus disease (COVID-19), a recent study has found. Such persistent symptoms seem to be more common among patients with lower serum levels of immunoglobulin (Ig) A.
